Inside Rx: Discounts Available for Insulin and Other Diabetes Medications
By Lynn Kennedy and Helen Gao
Express Scripts recently announced the launch of Inside Rx, a discount prescription program with savings ranging from 16% to nearly 80% for insulin and other diabetes medications
Express Scripts recently announced the launch of Inside Rx, a direct discount program in partnership with GoodRx that will allow some people with diabetes to save on branded insulin and other diabetes medications at nearly 40,000 participating pharmacies in the US or Puerto Rico (excluding Tennessee for now). With average discounts of 34%, the program targets people without insurance or those whose health plans have high out-of-pocket costs (i.e., high deductible plans, large coinsurance, etc.).
The currently available Inside Rx discounts range from 16% to nearly 80% for diabetes medications from four big drug makers: AstraZeneca, Lilly/BI, Novo Nordisk, and Sanofi. The discounts seem to be greater for insulin products (mostly in the 40%-50% range) than for diabetes pills (around 20%-30% off). See below for a full list of diabetes medications currently available for discounted purchase with an Inside Rx card (including Jardiance, Tradjenta, and Onglyza). Note that GLP-1 agonists (e.g., Bydureon, Victoza, Lyxumia, and Trulicity) are not yet included in the program.
Who will likely benefit from Inside Rx discounts? The program is designed to reduce out-of-pocket drug costs. It is targeted at people without insurance and those whose health plans have a significant level of cost-sharing (i.e., high deductible plans).
Who is eligible for Inside Rx discounts? To be eligible, Continue reading